DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 ...

Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors.  | Dexcom said Smart Basal is the ...

Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...

BAGSVAERD, Denmark, Sept. 22, 2020 /PRNewswire/ -- Today, Novo Nordisk announced results from three phase 2 clinical trials for insulin icodec, an investigational once-weekly basal insulin analogue, ...

Please provide your email address to receive an email when new articles are posted on . Change in HbA1c and hypoglycemia rates were similar between once-weekly basal insulin and once-daily insulin ...

INDIANAPOLIS, June 6, 2015 /PRNewswire/ -- In newly released Phase III trial data, Eli Lilly and Company's (NYSE: LLY) basal insulin peglispro (BIL) demonstrated statistically significantly lower ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Once-weekly insulin efsitora alfa was noninferior to ...

DexCom (DXCM) announced the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for ...

Diabetes is a condition that interferes with blood sugar levels in people whose bodies don't produce the right amount of insulin — a hormone made in the pancreas. Blood sugar that’s too high ...

Hypoglycemia after basal insulin initiation is associated with high clinical and economic burden that precedes insulin initiation and persists during 1 to 2 years of follow-up. Objectives: To assess ...

With Eli Lilly’s insulin glargine biosimilar on a 30-month hold for alleged patent infringement, the company may find another route to the basal insulin market—this one discovered in its own labs. The ...

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...